These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 9870256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
    Haque T, Crawford DH.
    Springer Semin Immunopathol; 1998; 20(3-4):375-87. PubMed ID: 9870252
    [No Abstract] [Full Text] [Related]

  • 4. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
    Green M, Reyes J, Webber S, Rowe D.
    Transpl Infect Dis; 2001 Jun; 3(2):97-103. PubMed ID: 11395975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of Posttransplant Lymphoproliferative Disorder in Pediatric Patients With a Liver Transplant.
    Aliakbarian M, Dehghani SM, Geramizadeh B, Nikeghbalian S, Kasiri K, Kazemi K, Shamsaeefar A, Bahador A, Malekhosseini SA.
    Exp Clin Transplant; 2015 Oct; 13(5):426-9. PubMed ID: 25232740
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus: evasive maneuvers in the development of PTLD.
    Snow AL, Martinez OM.
    Am J Transplant; 2007 Feb; 7(2):271-7. PubMed ID: 17229074
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.
    Meijer E, Dekker AW, Weersink AJ, Rozenberg-Arska M, Verdonck LF.
    Br J Haematol; 2002 Dec; 119(3):596-607. PubMed ID: 12437632
    [No Abstract] [Full Text] [Related]

  • 11. The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.
    AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S.
    Am J Transplant; 2017 Mar; 17(3):770-781. PubMed ID: 27545492
    [Abstract] [Full Text] [Related]

  • 12. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Mar; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 13. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
    [Abstract] [Full Text] [Related]

  • 14. Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome.
    Takahashi T, Oeda E, Sato Y, Tanizawa Y.
    Int J Hematol; 2002 Oct; 76(3):290-1. PubMed ID: 12416743
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus and posttransplant lymphoproliferative disease.
    Holmes R.
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus and lymphoproliferative disorders after transplantation.
    Am J Transplant; 2004 Nov; 4 Suppl 10():59-65. PubMed ID: 15504214
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.